期刊文献+

宫颈癌患者CEA和SCC-Ag血清水平联合检测的临床应用价值 被引量:32

Clinical characteristic of CEA and SCC-Ag in patients with cervical cancer
下载PDF
导出
摘要 目的:探讨癌胚抗原(CEA)和鳞状细胞癌抗原(SCC-Ag)血清水平联合检测对宫颈癌患者的临床诊断、分期、分型,病理类型和疗效观察的价值。方法:采用酶联免疫吸附法(ELISA)以100名健康人做对照,检测217例宫颈癌患者,其中手术或放射治疗后119例CEA与SCC-Ag血清水平。结果:宫颈癌患者CEA与SCC-Ag血清水平明显高于健康人,P<0.01;SCC-Ag检测宫颈癌的敏感度、准确度和阴性预测值明显高于CEA,均P<0.01;宫颈癌分期(0期-Ⅲ期)CEA和SCC-Ag血清水平组间比较,均P<0.01;宫颈癌分型(糜烂型、外生型、内生型和溃疡型)CEA和SCC-Ag血清水平组间比较,均P<0.01;治疗后缓解(CR+PR)的患者CEA和SCC-Ag血清水平明显下降,P<0.01,未缓解(MR+PD)的患者明显升高,P<0.05。另外,在检测的5例宫颈腺癌患者中有4例CEA血清水平高于界值,2例SCC-Ag高于界值。结论:宫颈癌患者CEA和SCC-Ag血清水平均明显升高,SCC-Ag对宫颈癌的诊断要优于CEA,而CEA对宫颈腺癌的诊断可能是一个良好的指标。两项检测对宫颈癌的分期,分型均有临床指导意义,特别是对宫颈癌的疗效观察作用明显,有重要的参考价值。 Objective:To study the clinical characteristics of CEA and SCC -Ag in patients with cervical cancer. Methods:Serum level of CEA and SCC -Ag was measured by ELISA in 217 patients with cervical cancer, and 100 healthy subjects, 119 patients with cervical cancer before and after treatment were also measured. Results:The serum level of CEA and SCC - Ag significantly increased in patients with cervical cancer as compared to that of the healthy subjects( P 〈 0.01 ). The sensitivity, accuracy and NPV of diagnosis with SCC -Ag in cervical cancer patients was significantly higher than that with CEA( P 〈0. Ol ). Among the four stages(O - Ⅲ ) ,the serum levels of CEA and SCC - Ag were significantly different( P 〈 0.01 ), among the four morphologys ( erosive, Exogenous, Endogenous and ulcerative types), the serum levels of CEA and SCC - Ag in erosive cervical cancer was significantly lower than that in the other three groups( P 〈0.01 ). In 88 patients with belief after treatment the levels of CEA and SCC - Ag was sig- nificantly lower than that before treatment, but in the 31 patients without belief the levels were significantly higher than that before treatment. In addition, in 5 patients with cervical adenomatous carcinoma, there was 4 patients that the CEA was higher than the cut - off value,and only 2 patients that the SCC - Ag was higher than the cut - off value. Conclusion: The serum levels of CEA and SCC - Ag in patients with cervical cancer were both increased. SCC - Ag is a more sensitive marker than CEA for the diagnosis of cervical cancer. CEA maybe a good marker for cervical adenom- atous carcinoma. Both of the two markers is useful for cervical carcinoma staging and typing, especially for treatment assessment.
出处 《现代肿瘤医学》 CAS 2013年第10期2316-2318,共3页 Journal of Modern Oncology
关键词 宫颈癌 CEA SCC-AG 临床特征分析 cervical cancer CEA SCC - Ag clinical characteristic
  • 相关文献

参考文献10

  • 1Pakin DM, dray F, Ferlay J, et al. Estimating the world cancer bur- den:Globocan 2000[ J]. Int J Cancer,2001,94(2) :153 - 156.
  • 2章文华,白萍,吴令英,马绍康.35岁以下妇女宫颈癌[J].中国肿瘤临床与康复,1999,6(6):39-41. 被引量:127
  • 3Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma [ J ]. Cancer, 1997,40 : 1621.
  • 4Bolger BS,lopes DA, monaghanm JA, et al. Prognostic value of pre- operative squamous cell carcinoma antigen level in patients surgi- cally treated for cervical carcinoma[J]. Gynecol Oncol, 1997,65: 309 -313.
  • 5何华,钟玲.联合检测ER、Vimentin、CK8/18、CEA对子宫内膜腺癌和宫颈腺癌鉴别诊断的意义[J].中国肿瘤临床,2005,32(7):392-394. 被引量:3
  • 6Duk JM, Groenier KH, de Bruijn HW, et al. Pretreatment serum squamous cen carcinoma antigen:a newly identified prognostic fac- tor in early - stage cervical carcinoma[ J]. J Clin Oncol, 1996,14 (1):111.
  • 7李俊东,李孟达,黄欣,李艳芳,刘富元,刘继红.治疗前血清SCC-Ag与宫颈癌生物学行为的相关性及其临床意义[J].中国实验诊断学,2002,6(2):69-71. 被引量:7
  • 8王喜青,邓敬兰,汪静,沈建军,梁晓燕.鳞状上皮细胞癌抗原检测在宫颈鳞癌中的临床意义[J].现代肿瘤医学,2011,19(2):336-337. 被引量:4
  • 9Yoon SM, Shin KH, Kim, JY, et al. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiothrapy[ J]. Int J Gynecol Cancer,2007,17 (4) : 872.
  • 10阳志军,李力,李菲,等.SCC-Ag在宫颈癌鳞状细胞癌中的临床价值[J].肿瘤预防与防治,2010,2:97.

二级参考文献30

  • 1高玉堂.我国常见恶性肿瘤的发病趋势[J].中国肿瘤,1996,5(1):3-6. 被引量:34
  • 2赵欣,邵淑丽.鳞状上皮细胞癌抗原与宫颈鳞癌[J].国外医学(妇产科学分册),2007,34(1):60-62. 被引量:17
  • 3章文华 王建璋.宫颈癌.癌症的初期警号及防治[M].北京:知识出版社,1992.98-105.
  • 4楼洪坤 胡悦倩 等.青年妇女宫颈浸润癌[J].中华肿瘤杂志,1983,5:293-295.
  • 5Duk JM, Groeneier KH, de -Bruijn HW, et al. Pretreatment serum squamous cell carcinoma antigen a newly identified prognosis factor in early -stage cervical carcinoma[ J]. J Clin Oncol, 1996, 14( 1):111-118.
  • 6Takeshima N. The value of squamous cell carcinoma antigen as a predictor of nodal metastasis in cervical cancer [ J ] . Gynecol Oncol, 1998,68(3) :263-266.
  • 7Reesink - Peters N, van der Velden J, Ten Hoor KA, et al. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early - stage cervical cancer [ J ]. J Clin Oncol, 2005,23(7) :1455 -1462.
  • 8Ohno T, Nakayama Y, Nakamoto S. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix [ J] . Cancer,2003,97 (12) :3114-3120.
  • 9Micke O, Bruns F, Schafer U, et al. The impact of squamous cell carcinoma antigen in patients with advanced cancer of uterine cervix treated with chemo - radiotherapy [ J ] . Anticancer Res, 2005,25 (3A) :1663 - 1666.
  • 10Ogino I, Nakayama H, Kitamura T, et al. The curative role of radiotherapy in patients with isolated para - aortic node recurrence from cervical cancer and value of squamous cell carcinoma antigen for early detection[ J] . Int J Gynecol Cancer, 2005, 15 (4) :630 - 638.

共引文献137

同被引文献274

引证文献32

二级引证文献197

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部